Thank you very much.
We are in somewhat of a unique position among Canadian universities, because we do have an HIV/AIDS vaccine in development right now.
With respect to what I've heard about capacity and quality, our experience has been that it takes nearly 18 months to source a facility to produce the vaccine for clinical trial lots, and it is very expensive. There were only three facilities that were shortlisted. We chose a facility in the U.S., though I won't name it. We are now ready to move to trials in the U.S. FDA approval has been held up with respect to issues regarding quality.
So I think there's a difference between the theoretical and the practical, but I wanted to give you an example of an actual experience that we've had.